Glaukos Corporation (GKOS) financial statements (2020 and earlier)
Company profile
| Business Address |
229 AVENIDA FABRICANTE SAN CLEMENTE, CA 92672 |
| State of Incorp. | DE |
| Fiscal Year End | December 31 |
| SIC | 3841 - Surgical and Medical Instruments and Apparatus (benchmarking) |
| More info | Complete financial analysis Financial benchmarking |
Balance sheet (Statement of financial position) ($ in millions)
| 12/31/2019 | 12/31/2018 | 12/31/2017 | 12/31/2016 | 12/31/2015 | |||
|---|---|---|---|---|---|---|---|
| ASSETS | |||||||
| Current Assets | |||||||
| Cash, cash equivalents, and short-term investments, including: | 183 | 149 | 119 | 96 | 91 | ||
| Cash and cash equivalents | 62 | 30 | 25 | 6 | 22 | ||
| Other undisclosed cash, cash equivalents, and short-term investments | 121 | 119 | 94 | 89 | 70 | ||
| Restricted cash and investments | 0 | 0 | |||||
| Receivables | 38 | 19 | 17 | 14 | 8 | ||
| Inventory, net of allowances, customer advances and progress billings | 43 | 13 | 11 | 7 | 4 | ||
| Inventory | 43 | 13 | 11 | 7 | 4 | ||
| Other undisclosed current assets | (1) | (5) | 3 | 3 | 1 | ||
| Total current assets: | 263 | 177 | 149 | 120 | 104 | ||
| Noncurrent Assets | |||||||
| Finance lease, right-of-use asset | 54 | ✕ | ✕ | ✕ | ✕ | ||
| Operating lease, right-of-use asset | 16 | ✕ | ✕ | ✕ | ✕ | ||
| Property, plant and equipment | 22 | 19 | 12 | 8 | 2 | ||
| Intangible assets, net (including goodwill) | 449 | 3 | 7 | 10 | |||
| Goodwill | 66 | ||||||
| Intangible assets, net (excluding goodwill) | 383 | 3 | 7 | 10 | |||
| Restricted cash and investments | 9 | ||||||
| Deferred costs | 4 | 2 | 1 | ||||
| Deferred tax assets, net | ✕ | 0 | 0 | ||||
| Other undisclosed noncurrent assets | 2 | 9 | 1 | 0 | 0 | ||
| Total noncurrent assets: | 556 | 30 | 16 | 14 | 13 | ||
| TOTAL ASSETS: | 818 | 207 | 166 | 134 | 117 | ||
| LIABILITIES AND EQUITY | |||||||
| Liabilities | |||||||
| Current Liabilities | |||||||
| Accounts payable and accrued liabilities | 58 | 30 | 27 | 17 | 11 | ||
| Accounts payable | 6 | 6 | 6 | 3 | 4 | ||
| Accrued liabilities | 52 | 24 | 20 | 14 | 8 | ||
| Debt | 9 | ||||||
| Deferred rent credit | 0 | ✕ | ✕ | ✕ | |||
| Deferred revenue and credits | ✕ | ✕ | 0 | 0 | 0 | ||
| Total current liabilities: | 58 | 30 | 27 | 17 | 20 | ||
| Noncurrent Liabilities | |||||||
| Long-term debt and lease obligation | 73 | 1 | |||||
| Long-term debt, excluding current maturities | 1 | ||||||
| Finance lease, liability | 58 | ✕ | ✕ | ✕ | ✕ | ||
| Operating lease, liability | 14 | ✕ | ✕ | ✕ | ✕ | ||
| Liabilities, other than long-term debt | 15 | 3 | 1 | 0 | 0 | ||
| Deferred income tax liabilities | 10 | ✕ | ✕ | ✕ | ✕ | ||
| Other liabilities | 5 | 3 | 1 | 0 | 0 | ||
| Other undisclosed noncurrent liabilities | 0 | ||||||
| Total noncurrent liabilities: | 87 | 3 | 1 | 0 | 1 | ||
| Total liabilities: | 145 | 33 | 28 | 17 | 21 | ||
| Stockholders' equity | |||||||
| Stockholders' equity attributable to parent | 673 | 174 | 138 | 117 | 95 | ||
| Common stock | 0 | 0 | 0 | 0 | 0 | ||
| Treasury stock, value | (0) | (0) | (0) | (0) | (0) | ||
| Additional paid in capital | 862 | 378 | 331 | 309 | 292 | ||
| Accumulated other comprehensive income (loss) | 1 | 1 | (1) | 1 | 0 | ||
| Accumulated deficit | (190) | (205) | (192) | (192) | (197) | ||
| Total stockholders' equity: | 673 | 174 | 138 | 117 | 95 | ||
| TOTAL LIABILITIES AND EQUITY: | 818 | 207 | 166 | 134 | 117 | ||
Income statement (P&L) ($ in millions)
| 12/31/2019 | 12/31/2018 | 12/31/2017 | 12/31/2016 | 12/31/2015 | ||
|---|---|---|---|---|---|---|
| Revenues | 237 | 181 | 159 | 114 | 72 | |
| Revenue, net | ✕ | ✕ | 159 | 114 | 72 | |
| Cost of revenue (Cost of Goods and Services Sold) | (39) | (25) | (21) | (16) | (13) | |
| Gross profit: | 198 | 156 | 138 | 98 | 59 | |
| Operating expenses | (249) | (169) | (140) | (94) | (69) | |
| Operating income (loss): | (50) | (13) | (2) | 4 | (10) | |
| Nonoperating income (expense) | 0 | 1 | 2 | 0 | (28) | |
| Investment income, nonoperating | (0) | (0) | (26) | |||
| Foreign currency transaction gain (loss), before tax | (0) | 0 | (1) | |||
| Other nonoperating expense | (2) | |||||
| Interest and debt expense | (3) | (0) | ||||
| Income (loss) from continuing operations before equity method investments, income taxes: | (53) | (12) | 0 | 5 | (38) | |
| Other undisclosed income from continuing operations before income taxes | 3 | 0 | ||||
| Income (loss) from continuing operations before income taxes: | (50) | (12) | 0 | 5 | (38) | |
| Income tax expense (benefit) | 65 | (1) | (0) | (0) | (0) | |
| Net income (loss): | 15 | (13) | (0) | 5 | (38) | |
| Net income attributable to noncontrolling interest | 1 | |||||
| Net income (loss) available to common stockholders, diluted: | 15 | (13) | (0) | 5 | (37) | |
Comprehensive Income ($ in millions)
| 12/31/2019 | 12/31/2018 | 12/31/2017 | 12/31/2016 | 12/31/2015 | ||
|---|---|---|---|---|---|---|
| Net income (loss): | 15 | (13) | (0) | 5 | (38) | |
| Other comprehensive income (loss) | 1 | 1 | (1) | 1 | 0 | |
| Comprehensive income (loss): | 16 | (12) | (1) | 5 | (38) | |
| Comprehensive income, net of tax, attributable to noncontrolling interest | 1 | |||||
| Comprehensive income (loss), net of tax, attributable to parent: | 16 | (12) | (1) | 5 | (37) | |
Statements sources
The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.